These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
296 related articles for article (PubMed ID: 29273015)
21. Preoperative Contrast-Enhanced CT Versus ¹⁸F-FDG PET/CT Evaluation and the Prognostic Value of Extranodal Extension for Surgical Patients with Head and Neck Squamous Cell Carcinoma. Lee JR; Choi YJ; Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1020-7. PubMed ID: 26122372 [TBL] [Abstract][Full Text] [Related]
22. Clinical utility of Ha SC; Roh JL; Kim JS; Lee JH; Choi SH; Nam SY; Kim SY Acta Otolaryngol; 2019 Sep; 139(9):810-815. PubMed ID: 31274365 [No Abstract] [Full Text] [Related]
23. Evaluation of 18F-FDG PET/CT and CT/MRI with histopathologic correlation in patients undergoing salvage surgery for head and neck squamous cell carcinoma. Kim SY; Kim JS; Yi JS; Lee JH; Choi SH; Nam SY; Cho KJ; Lee SW; Kim SB; Roh JL Ann Surg Oncol; 2011 Sep; 18(9):2579-84. PubMed ID: 21409485 [TBL] [Abstract][Full Text] [Related]
24. The Importance of the Time Interval Between Preoperative 18F-FDG PET/CT Imaging and Neck Dissection for the Detection of Nodal Metastases in Patients with Head and Neck Squamous Cell Carcinoma. Koroglu E; Sirin S; Isgoren S Niger J Clin Pract; 2024 Jul; 27(7):859-864. PubMed ID: 39082911 [TBL] [Abstract][Full Text] [Related]
25. Pretreatment maximum standardized uptake value of (18)F-fluorodeoxyglucose positron emission tomography as a predictor of distant metastasis in adenoid cystic carcinoma of the head and neck. Kim D; Kim W; Lee J; Ki Y; Lee B; Cho K; Kim S; Nam J; Lee J; Kim D Head Neck; 2016 May; 38(5):755-61. PubMed ID: 25524466 [TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of clinical and Cho JK; Hyun SH; Choi JY; Choi N; Kim MJ; Lee SH; Baek KH; Jeong HS J Surg Oncol; 2016 Dec; 114(7):888-894. PubMed ID: 27546387 [TBL] [Abstract][Full Text] [Related]
28. 18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation. Ng SH; Yen TC; Liao CT; Chang JT; Chan SC; Ko SF; Wang HM; Wong HF J Nucl Med; 2005 Jul; 46(7):1136-43. PubMed ID: 16000282 [TBL] [Abstract][Full Text] [Related]
29. 18F fluorodeoxyglucose PET/CT in head and neck squamous cell carcinoma with negative neck palpation findings: a prospective study. Roh JL; Park JP; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY Radiology; 2014 Apr; 271(1):153-61. PubMed ID: 24475791 [TBL] [Abstract][Full Text] [Related]
30. Prospective study of [18F]fluorodeoxyglucose positron emission tomography and computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with palpably negative neck. Ng SH; Yen TC; Chang JT; Chan SC; Ko SF; Wang HM; Lee LY; Kang CJ; Wong AM; Liao CT J Clin Oncol; 2006 Sep; 24(27):4371-6. PubMed ID: 16983105 [TBL] [Abstract][Full Text] [Related]
31. Impact of 3T multiparametric MRI and FDG-PET-CT in the evaluation of occult primary cancer with cervical node metastasis. Gődény M; Lengyel Z; Polony G; Nagy ZT; Léránt G; Zámbó O; Remenár É; Tamás L; Kásler M Cancer Imaging; 2016 Nov; 16(1):38. PubMed ID: 27814768 [TBL] [Abstract][Full Text] [Related]
32. Change of maximum standardized uptake value slope in dynamic triphasic [18F]-fluorodeoxyglucose positron emission tomography/computed tomography distinguishes malignancy from postradiation inflammation in head-and-neck squamous cell carcinoma: a prospective trial. Anderson CM; Chang T; Graham MM; Marquardt MD; Button A; Smith BJ; Menda Y; Sun W; Pagedar NA; Buatti JM Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):472-9. PubMed ID: 25680593 [TBL] [Abstract][Full Text] [Related]
33. Diagnostic evaluation of malignant head and neck cancer by F-18-FDG PET compared to CT/MRI. Nowak B; Di Martino E; Jänicke S; Cremerius U; Adam G; Zimny M; Reinartz P; Büll U Nuklearmedizin; 1999; 38(8):312-8. PubMed ID: 10615664 [TBL] [Abstract][Full Text] [Related]
34. [Correlation of FDG-PET and MRI/CT with histopathology in primary diagnosis, lymph node staging and diagnosis of recurrency of head and neck cancer]. Pöpperl G; Lang S; Dagdelen O; Jäger L; Tiling R; Hahn K; Tatsch K Rofo; 2002 Jun; 174(6):714-20. PubMed ID: 12063600 [TBL] [Abstract][Full Text] [Related]
35. [Results of pretherapeutic lymph node diagnosis in head and neck tumors. Clinical value of 18-FDG positron emission tomography (PET)]. Di Martino E; Nowak B; Krombach GA; Sellhaus B; Hausmann R; Cremerius U; Büll U; Westhofen M Laryngorhinootologie; 2000 Apr; 79(4):201-6. PubMed ID: 10838683 [TBL] [Abstract][Full Text] [Related]
36. [(18)F]-FDG PET/CT imaging for detection of nodal metastases in patients with squamous cell carcinoma of the pharynx and larynx: comparison with CT. Suenaga Y; Kitajima K; Kanda T; Otsuki N; Nibu K; Sasaki R; Itoh T; Sugimura K Jpn J Radiol; 2016 Mar; 34(3):203-10. PubMed ID: 26670594 [TBL] [Abstract][Full Text] [Related]
37. The combination of preoperative PET/CT and sentinel lymph node biopsy in the surgical management of early-stage cervical cancer. Papadia A; Gasparri ML; Genoud S; Bernd K; Mueller MD J Cancer Res Clin Oncol; 2017 Nov; 143(11):2275-2281. PubMed ID: 28669052 [TBL] [Abstract][Full Text] [Related]
38. Cervical lymph node metastases of squamous cell carcinoma of unknown origin: the diagnostic value of FDG PET/CT and clinical outcome. Dale E; Moan JM; Osnes TA; Bogsrud TV Eur Arch Otorhinolaryngol; 2017 Feb; 274(2):1015-1019. PubMed ID: 27671150 [TBL] [Abstract][Full Text] [Related]
39. Accuracy of (18) FDG PET-CT for treatment evaluation 3 months after completion of chemoradiotherapy for head and neck squamous cell carcinoma: 2-year minimum follow-up. Sagardoy T; Fernandez P; Ghafouri A; Digue L; Haaser T; de Clermont-Galleran H; Castetbon V; de Monès E Head Neck; 2016 Apr; 38 Suppl 1():E1271-6. PubMed ID: 26315809 [TBL] [Abstract][Full Text] [Related]
40. Evaluation of 18F-FDG PET/CT and CT/MRI with histopathologic correlation in patients undergoing central compartment neck dissection for squamous cell carcinoma of the larynx, hypopharynx, and esophagus. Kim JW; Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY Oral Oncol; 2013 May; 49(5):449-53. PubMed ID: 23321549 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]